Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6488
Source ID: NCT00464061
Associated Drug: Volinanserin
Title: Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus
Acronym: SAMS
Status: TERMINATED
Study Results: NO
Results:
Conditions: Sleep Initiation and Maintenance Disorders
Interventions: DRUG: Volinanserin|DRUG: Placebo
Outcome Measures: Primary: Efficacy: change from baseline for Sleep Maintenance Insomnia using patient reported Wake After Sleep Onset (pr-WASO), at 3 months|Efficacy (sub-study): change from baseline for glycemic measure HbA1c, at 6 and 12 months | Secondary: Efficacy: change from baseline of the pr-WASO, at 6 and 12 months|Efficacy: change from baseline of "General Productivity" domain score of the Functional Outcomes of Sleep Questionnaire, at 3 months|Safety: adverse events and laboratory abnormalities, during 12 months of treatment
Sponsor/Collaborators: Sponsor: Sanofi
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 1847
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2007-04
Completion Date: 2009-03
Results First Posted:
Last Update Posted: 2016-05-26
Locations: Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, 08807, United States|Sanofi-Aventis Administrative Office, Buenos Aires, Argentina|Sanofi-Aventis Administrative Office, Macquarie Park, Australia|Sanofi-Aventis Administrative Office, Vienna, Austria|Sanofi-Aventis Administrative Office, Diegem, Belgium|Sanofi-Aventis Administrative Office, Sao Paulo, Brazil|Sanofi-Aventis Administrative Office, Laval, Canada|Sanofi-Aventis Administrative Office, Santiago, Chile|Sanofi-Aventis Administrative Office, Santafe de Bogota, Colombia|Sanofi-Aventis Administrative Office, Praha, Czech Republic|Sanofi-Aventis Administrative Office, Berlin, Germany|Anofi-Aventis Administrative Office, Causeway Bay, Hong Kong|Sanofi-Aventis Administrative Office, Mumbai, India|Sanofi-Aventis Administrative Office, Milano, Italy|Sanofi-Aventis Administrative Office, Kuala Lumpur, Malaysia|Sanofi-Aventis Administrative Office, Mexico, Mexico|Sanofi-Aventis Administrative Office, Moscow, Russian Federation|Sanofi-Aventis Administrative Office, Singapore, Singapore|Sanofi-Aventis Administrative Office, Midrand, South Africa|Sanofi-Aventis Administrative Office, Barcelona, Spain|Sanofi-Aventis Administrative Office, Istanbul, Turkey|Sanofi-Aventis Administrative Office, Guildford, Surrey, United Kingdom
URL: https://clinicaltrials.gov/show/NCT00464061